Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02841618 · ClinicalTrials.gov registry record · NA

The Healthy Cookie Study: Understanding How Healthy Cookies Affect Fat in the Blood,

A NA study of Healthy Adults, sponsored by Ohio State University.

Active
Registry status
NA
Development phase
123
Enrollment target
1
Study location

NCT02841618: Active NA study of Healthy Adults, sponsored by Ohio State University.

NCT02841618 is a NA study of Healthy Adults that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 123 participants, above the 83-participant average among 33 other Healthy Adults trials with a reported enrollment target (48% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02841618, a NA study of Healthy Adults, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
123 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand how consuming healthy cookies every day for two weeks will affect different types of fat in the blood. Specifically, the overall goal of this study is to find out if the healthy cookies can increase a polyunsaturated fat called linoleic acid in plasma, red blood cells and white blood cells.

Primary Outcome

Linoleic acid content of fasting blood samples

Conditions Studied

Interventions

  • OTHER High Linoleic Acid Healthy Cookies
  • OTHER High Oleic Acid Healthy Cookies

Study Locations (1)

Ohio

  • The Ohio State University Human Nutrition Laboratory - Columbus

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2016-01
Est. Completion 2026-12-01
Phase NA
Ohio State University

552 total trials

What the registry record for NCT02841618 still lists

NCT02841618 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 33 other Healthy Adults trials with a reported enrollment target (48% higher).

The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 2 interventions - of which High Linoleic Acid Healthy Cookies is the first listed.

NCT02841618 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02841618 about?

NCT02841618 is a clinical study titled "The Healthy Cookie Study: Understanding How Healthy Cookies Affect Fat in the Blood,". The purpose of this study is to understand how consuming healthy cookies every day for two weeks will affect different types of fat in the blood. Specifically, the overall goal of this study is to find out if the healthy cookies can increase a polyunsaturated fat called linoleic acid in plasma, red ...

What is the current status of trial NCT02841618?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2016-01. Estimated completion is 2026-12-01.

What conditions does trial NCT02841618 study?

This clinical trial studies the following conditions: Healthy Adults.

What interventions are being tested in trial NCT02841618?

The interventions under investigation include: High Linoleic Acid Healthy Cookies (OTHER), High Oleic Acid Healthy Cookies (OTHER).

Who is sponsoring clinical trial NCT02841618?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02841618 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Adults

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02841618's enrollment target sits among peer trials

123 4th of 33 higher than 30 of 33 other Healthy Adults trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05285891 · 123 participants · Phase 4

    Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

  • NCT05334368 · 123 participants · Phase 3

    Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

  • NCT06088355 · 123 participants · NA

    Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

  • NCT06111131 · 123 participants · NA

    Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02841618, the US trial registry maintained by the National Library of Medicine. NCT02841618 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.